Lukas Hainz

Lukas Hainz

Biopharma Innovation Specialist
Lukas Hainz specializes in biopharmaceutical research and development. He unpacks research from clinical trials and explores regulatory affairs implications on the pharmaceutical industry, focusing on innovative therapies and patent development.
Will Telehealth and Government Funding Survive Political Division?
Management & Administration Will Telehealth and Government Funding Survive Political Division?

The U.S. House of Representatives recently voted to extend telehealth flexibilities for Medicare and passed a continuing resolution funding the federal government through September 30. The vote, showing a 217-213 margin, highlights the political divide in healthcare and government funding issues.

Will FDA's AI-Driven Move End Animal Testing in Drug Development?
Clinical & Pharma Will FDA's AI-Driven Move End Animal Testing in Drug Development?

The announcement from the U.S. Food and Drug Administration (FDA) to gradually phase out animal testing marks a revolutionary shift in drug development. This groundbreaking change aims to replace traditional testing methods with artificial intelligence (AI) and other advanced technologies,

How Can Hospitals Thrive Under the Two-Midnight Medicare Rule?
Management & Administration How Can Hospitals Thrive Under the Two-Midnight Medicare Rule?

How can a hospital ensure compliance and optimize patient care while navigating complex Medicare guidelines? This question has become increasingly pertinent for many healthcare institutions. Did you know that inpatient stays account for significant revenue for hospitals compared to outpatient

Legislature Tackles Crisis at Underfunded Virgin Islands Hospital
Management & Administration Legislature Tackles Crisis at Underfunded Virgin Islands Hospital

The financial and operational turmoil at the Gov. Juan F. Luis Hospital (JFL) in the Virgin Islands highlights a significant challenge that demands immediate legislative attention. Medical professionals have sounded alarms over unmanageable working conditions and precarious hospital safety, pushing

ECRI Identifies AI as Top Healthcare Hazard for 2025
Tech & Innovation ECRI Identifies AI as Top Healthcare Hazard for 2025

Artificial intelligence's (AI) role in healthcare has been lauded for revolutionizing diagnostic and treatment methods, yet recent findings by ECRI suggest that this technological boon is not without significant risks. As AI becomes more integrated into medical practices, it brings forth new

GE Healthcare Ultrasound Devices Exposed to Cybersecurity Risks
Tech & Innovation GE Healthcare Ultrasound Devices Exposed to Cybersecurity Risks

Nozomi Networks Labs has discovered cybersecurity vulnerabilities in GE Healthcare's ultrasound devices and software. The cybersecurity group identified 11 flaws across various systems and products, particularly highlighting issues in the Vivid line of ultrasound devices. These vulnerabilities

Will Australia's 2025 Aged Care Reforms Truly Address Sector Woes?
Care Providers Will Australia's 2025 Aged Care Reforms Truly Address Sector Woes?

As Australia ushers in substantial changes to its aged care system inspired by recommendations from the Royal Commission report, concerns remain regarding the adequacy of these reforms. The forthcoming alterations, encapsulated in the new Aged Care Act effective July 1, promise to enhance the care

Digital Health Startups Raise $3B in Q1 2025 Amid Strategic Mergers
Tech & Innovation Digital Health Startups Raise $3B in Q1 2025 Amid Strategic Mergers

The digital health sector experienced significant funding activities in the first quarter of 2025, with startups raising $3 billion. This funding represents an increase from the $2.7 billion raised in the same period last year. Despite a similar number of deals—122 compared to 133 last year—the ave

What Are the Latest Trends in US Healthcare Mergers and Acquisitions?
Management & Administration What Are the Latest Trends in US Healthcare Mergers and Acquisitions?

The landscape of healthcare mergers and acquisitions in the US is evolving rapidly, reflecting shifts in strategy, technology integration, and regulatory considerations. March has witnessed a series of notable transactions across providers, payers, and tech companies. This outline provides an

Understanding the Differences Between Common Cold and Flu
Clinical & Pharma Understanding the Differences Between Common Cold and Flu

Understanding distinguishing factors between the common cold and flu is crucial for accurate diagnosis, effective treatment, and proper preventive measures. Despite exhibiting similar symptoms, these respiratory illnesses are caused by different viruses and vary significantly in severity. An

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later